Additionally, through the computation of IPS for HCC samples, we found that patients classified in the high-risk group and exhibiting positive CTLA-4 and PD-1 expressions displayed elevated IPS scores (Fig. 7C–F). This evidence concerns the gene CTLA4 and hepatocellular carcinoma.